I-US Food and Drug Administration isandula ukwenza inyathelo elikhulu ekulweni nesifo se-Alzheimer ngokwamkela i-donanemab, i-antibody ye-monoclonal eyenziwe ngu-Eli Lilly. Olu nyango lutsha lujolise ekunciphiseni ukuqhubela phambili kwesifo se-Alzheimer's esineempawu zokuqala ngokunceda umzimba ususe i-amyloid plaque buildup engqondweni—uphawu lwe-Alzheimer's. Olu vunyiweyo alupheleli nje ekubonakaliseni ixesha elibalulekileyo kuphando lwe-Alzheimer's kodwa lukwagxininisa ukubaluleka kokubhaqwa kwangethuba kunye nokungenelela.
IKisunla: Isahluko esitsha kuNyango lwe-Alzheimer's
I-Donanemab, okanye iKisunla, ayilonyango lwe-Alzheimer's kodwa ibonakalise iziphumo ezithembisayo kuvavanyo lweklinikhi. Abathathi-nxaxheba abathathe iKisunla bafumana umngcipheko ophantsi ngama-35% wokuqhubeka kwesifo kwiinyanga ezili-18 xa kuthelekiswa nabo bathathe i-placebo. Oku kuthetha ukuba izigulana zinokuphila ngokuzimela ngakumbi kwaye zibandakanyeke ngokukhuselekileyo kwimisebenzi yemihla ngemihla ixesha elide.
Nangona kunjalo, kubalulekile ukuqaphela ukuba unyango alunazo iingozi. Malunga ne-2% yabathathi-nxaxheba baye bafumana iziganeko ezimbi kakhulu, kuquka ukungaqheleki kwemifanekiso enxulumene ne-amyloid (ARIA), enokukhokelela kwi-micro-hemorrhages engqondweni. Nangona ezi ngozi zinokwenzeka, abacebisi be-FDA baluthathe unyango njengolukhuselekileyo nolusebenzayo, ngenxa yezibonelelo zalo ezinokubakho.
Ukubaluleka Kokuchongwa Kwangethuba
Ukufunyanwa kwangethuba kunye nokuxilongwa kubalulekile kunyango olusebenzayo lwesifo se-Alzheimer. I-Kisunla isebenza kakuhle kumanqanaba okuqala eempawu, nto leyo ebangela ukuba u-Eli Lilly asebenzisane neminye imibutho ukuphucula iindlela zokufumanisa kwangethuba. Eli phulo lihambelana nesidingo esikhulayo sokungenelela kwangethuba, ingakumbi njengoko inani lamatyala e-Alzheimer kulindeleke ukuba lifikelele phantse kwi-14 yezigidi ngo-2060.
Indima yoNyango lwasekhaya kuLawulo lwe-Alzheimer's
Njengoko isifo sika-Alzheimer siqhubeka, indima yabanakekeli ibaluleka ngakumbi. Abanakekeli abagcina ikhaya, ababonelela ngononophelo oluqhubekayo kunye nenkxaso, badlala indima ebalulekileyo ekuqinisekiseni ukhuseleko kunye nokuphila kakuhle kwezigulane zika-Alzheimer. Kwiintsapho ezilawula i-Alzheimer's ekhaya, iimveliso ezifana nezo zinikezelwa yi-LIREN Healthcare zinokuba luncedo kakhulu.
I-LIREN Healthcare igxile kwiimveliso zonyango lwabantu abadala ezenzelwe ukuphucula ukhuseleko lwasekhaya kunye nokusebenza kakuhle kokhathalelo. Uluhlu lwethu luquka uxinzelelo lwebhedi kunye nesitulo.iipadi zesensor, ukulumkisaiipagerkunyeamaqhosha okufowuna, zonke ezi zinto zibalulekile ekudaleni imeko-bume yekhaya ekhuselekileyo nekhuselekileyo kubantu abadala.
Ukuphucula uKhuseleko lwasekhaya ngeeMveliso zezeMpilo zeLIREN
1. IiPads zeSensor yoXinzelelo: Ezi pads zibekwa kwiibhedi okanye kwizitulo ukuze zijonge iintshukumo kwaye zibone xa umntu omdala evuka, ngaloo ndlela zithintele ukuwa.
2. Ukulumkisa iiPagers: Ezi zixhobo zixelela abanakekeli ngoko nangoko xa umntu omdala efuna uncedo, ziqinisekisa impendulo ekhawulezileyo kwaye zinciphisa umngcipheko weengozi.
3. Amaqhosha okuFowuna: La manyathelo avumela abantu abadala ukuba bafowune becela uncedo ngokucindezela nje okulula, nto leyo enika uxolo lwengqondo kubo bobabini abaguli kunye nabanakekeli babo.
Ngokudibanisa iimveliso ze-LIREN Healthcare kwindawo yokhathalelo lwasekhaya, iintsapho zinokwenza indawo ekhuselekileyo kubantu ezibathandayo. Kwabo bacinga ngokufaka inkqubo ye-alamu yokhuseleko, ukufaka ii-pressure sensor pads kunye nee-alerting pagers kunokuba longezo olubalulekileyo kwinkqubo yokhathalelo lwasekhaya.
Ukhuseleko noxolo lwengqondo
Ukufakela inkqubo yokhuseleko equka iimveliso ze-LIREN Healthcare kunokuphucula kakhulu ukhuseleko lwesigulana esine-Alzheimer ekhaya. Inkqubo yethu yokufaka inkqubo ye-alamu yokhuseleko ilula kwaye yenzelwe ukubonelela ngokhuseleko oluphezulu ngaphandle kokuphazamiseka okukhulu.
Ukujonga Phambili
Ukuvunywa kweKisunla kubonisa inkqubela phambili ebalulekileyo kunyango lwe-Alzheimer's, okunika ithemba elitsha kwizigidi zabantu abachaphazelekileyo sesi sifo sibulalayo. Njengoko siqhubeka sihlola kwaye siphuhlisa unyango olutsha, indima yokhathalelo lwasekhaya kunye neemveliso ezintsha ezifana nezo zivela kwiLIREN Healthcare ziya kuba zibaluleke ngakumbi ekulawuleni isifo se-Alzheimer's.
Ukuze ufumane ulwazi oluthe kratya malunga nendlela iimveliso zeLIREN Healthcare ezinokukunceda ngayo ukudala imeko-bume yekhaya ekhuselekileyo kubantu obathandayo, ndwendwela iwebhusayithi yethu. Hlala unolwazi malunga nophuhliso lwamva nje kwinkonzo yokhathalelo lwempilo yabantu abadala kwaye ufumane izisombululo ezilungileyo zokuphucula umgangatho wobomi babantu abadala.
Isishwankathelo
Idabi lokulwa nesifo i-Alzheimer's alikapheli, kodwa ngenxa yempumelelo efana neKisunla kunye nenkxaso eqhubekayo yeemveliso zokhathalelo lwasekhaya ezivela kwiinkampani ezifana neLIREN Healthcare, kukho ithemba lekamva elingcono. Njengoko siwamkela la maphulo matsha, ukuqinisekisa ukhuseleko kunye nokuphila kakuhle kwezigulane ze-Alzheimer's kusaqhubeka nokuba yeyona nto iphambili kuthi.
Ndwendwela iwebhusayithi yeLIREN Healthcare namhlanje ukuze ufunde okungakumbi malunga neemveliso zethu kunye nendlela ezinokukunceda ngayo ukudala indawo ekhuselekileyo nekhuselekileyo yasekhaya kubantu obathandayo. Hlala uqhagamshelwe nathi ukuze ufumane iindaba zamva nje kunye nohlaziyo malunga nokhathalelo lwempilo yabantu abadala.
Umthombo weendaba:https://edition.cnn.com/2024/07/02/health/lilly-azheimers-donanemab-fda/index.html
I-LIREN ifuna abasasazi abasebenzisana nabo kwiimarike eziphambili. Amaqela anomdla akhuthazwa ukuba aqhagamshelane nabo ngokusebenzisacustomerservice@lirenltd.comukuze ufumane iinkcukacha ezithe vetshe.
Ixesha leposi: Julayi-08-2024
